{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:30:46Z","timestamp":1790883046604,"version":"4.1.0"},"reference-count":30,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Alzheimer disease (AD) is characterized by dysregulated gamma brain oscillations. Transcranial alternating current stimulation (tACS) is a novel, noninvasive brain stimulation technique capable of entraining cerebral oscillations at targeted frequencies.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To assess the safety, feasibility, and efficacy of home-based gamma tACS applied over the precuneus in patients with prodromal and mild AD.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This double-blind, randomized, sham-controlled clinical trial with an open-label extension phase was conducted at a tertiary AD research clinic in Italy from December 10, 2022, to October 15, 2024. Patients with a diagnosis of AD were eligible to participate.<\/jats:p>\n <\/jats:sec>\n \n Intervention<\/jats:title>\n Participants were randomized to receive either home-based gamma tACS (5 sessions\/wk, 60 minutes each) or sham stimulation for 8 weeks (double-blind phase). All participants subsequently received gamma tACS for an additional 8 weeks (open-label phase) and an 8-week follow-up.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n The primary end points were safety, feasibility, and clinical efficacy. Secondary end points included measures of biological efficacy, including gamma band power via electroencephalography, cholinergic neurotransmission, AD plasma biomarker levels, and brain connectivity as assessed via magnetic resonance imaging.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Sixty consecutive patients with prodromal or mild AD were screened; 50 were randomized to gamma or sham tACS (mean [SD] age, 67.3\u2009[7.8] years; 25 [50.0%] female and 25 [50.0%] male). Home-based gamma tACS was safe and well-tolerated. A significant enhancement in global cognitive functions, activities of daily living, and associative memory performances was observed. Marginal mean differences between the sham vs gamma tACS groups were significant for the Clinical Dementia Rating sum of boxes (0.35; 95% CI, 0.10-0.61;\n P<\/jats:italic>\n \u2009=\u2009.007), Alzheimer Disease Assessment Scale\u2013cognitive subscale (0.93; 95% CI, 0.50-1.36;\n P<\/jats:italic>\n \u2009=\u2009.001), Alzheimer Disease Cooperative Study\u2013Activities of Daily Living (\u22120.55; 95% CI, \u22120.89 to \u22120.21;\n P<\/jats:italic>\n \u2009=\u2009.02), and Face-Name Association Test (\u22121.14; 95% CI, \u22121.66 to \u22120.61;\n P<\/jats:italic>\n \u2264 .001). During the open-label phase, a significant marginal mean difference was observed for Alzheimer Disease Assessment Scale\u2013cognitive subscale (\u22120.59; 95% CI, \u22121.02 to \u22120.16;\n P<\/jats:italic>\n \u2009=\u2009.007), Alzheimer Disease Cooperative Study\u2013Activities of Daily Living (0.41; 95% CI, 0.04-0.08;\n P<\/jats:italic>\n \u2009=\u2009.02), and Face-Name Association Test (1.04; 95% CI, 0.50-1.57;\n P<\/jats:italic>\n \u2009=\u2009.003). Neurophysiological measures showed an increase in cholinergic transmission, coinciding with an increase in gamma power following gamma tACS, effects not seen with sham stimulation. No changes of plasma biomarkers were observed. No add-on effect was observed after 2 repeated treatments with gamma tACS, suggesting that 8 rather than 16 weeks of treatment represents the ideal duration.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this randomized clinical trial, home-based gamma tACS was feasible and improved clinical outcomes in AD, with neurophysiological evidence of brain engagement. These findings support further investigation of gamma tACS as a potential therapeutic intervention for AD.<\/jats:p>\n <\/jats:sec>\n \n Trial Registration<\/jats:title>\n \n ClinicalTrials.gov Identifier:\n NCT05643326<\/jats:ext-link>\n <\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.46556","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T16:00:27Z","timestamp":1765209627000},"page":"e2546556","source":"Crossref","is-referenced-by-count":21,"title":["Home-Based Gamma Transcranial Alternating Current Stimulation in Patients With Alzheimer Disease"],"prefix":"10.1001","volume":"8","author":[{"given":"Valentina","family":"Cantoni","sequence":"first","affiliation":[{"name":"Department of Continuity of Care and Frailty, Azienda Socio Sanitaria Territoriale (ASST) Spedali Civili of Brescia, Brescia, Italy"},{"name":"Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias Paolo","family":"Casula","sequence":"additional","affiliation":[{"name":"Department of Clinical and Behavioural Neurology, Santa Lucia Foundation Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy"},{"name":"Department of System Medicine, Tor Vergata University, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Tarantino","sequence":"additional","affiliation":[{"name":"Department of Brain and Behavioural Sciences, Medical and Genomic Statistics Unit, University of Pavia, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Cupidi","sequence":"additional","affiliation":[{"name":"Neurology Unit, Fondazione Istituto G. Giglio, Cefal\u00f9, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Huber","sequence":"additional","affiliation":[{"name":"A. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Altomare","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Premi","sequence":"additional","affiliation":[{"name":"Stroke Unit, ASST Spedali Civili, Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Zummo","sequence":"additional","affiliation":[{"name":"Neurology Unit, Fondazione Istituto G. Giglio, Cefal\u00f9, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romina","family":"Esposito","sequence":"additional","affiliation":[{"name":"Department of Clinical and Behavioural Neurology, Santa Lucia Foundation Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Leonardi","sequence":"additional","affiliation":[{"name":"Department of Clinical and Behavioural Neurology, Santa Lucia Foundation Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanna-Kaisa","family":"Herukka","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine, University of Eastern Finland, Kuopio"},{"name":"Neuro Center, Neurology, Kuopio University Hospital, Kuopio, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eino","family":"Solje","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine, University of Eastern Finland, Kuopio"},{"name":"Neuro Center, Neurology, Kuopio University Hospital, Kuopio, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asia","family":"Ferrari","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Sofia","family":"Cotelli","sequence":"additional","affiliation":[{"name":"Department of Continuity of Care and Frailty, Azienda Socio Sanitaria Territoriale (ASST) Spedali Civili of Brescia, Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Gasparotti","sequence":"additional","affiliation":[{"name":"Neuroradiology Unit, Department of Medical and Surgical Specialties, University of Brescia, Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Martorana","sequence":"additional","affiliation":[{"name":"Department of Systems Medicine, Memory Clinic, University of Rome Tor Vergata, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Fracassi","sequence":"additional","affiliation":[{"name":"Neurophysiology Lab, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emiliano","family":"Santarnecchi","sequence":"additional","affiliation":[{"name":"Precision Neuroscience and Neuromodulation Program, Gordon Center for Medical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Koch","sequence":"additional","affiliation":[{"name":"Department of Clinical and Behavioural Neurology, Santa Lucia Foundation Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy"},{"name":"Department of Neuroscience and Rehabilitation, University of Ferrara, Ferrara, Italy"},{"name":"Center for Translational Neurophysiology of Speech and Communication, Italian Institute of Technology, Ferrara, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annakaisa","family":"Haapasalo","sequence":"additional","affiliation":[{"name":"A. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Grassi","sequence":"additional","affiliation":[{"name":"Department of Brain and Behavioural Sciences, Medical and Genomic Statistics Unit, University of Pavia, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Benussi","sequence":"additional","affiliation":[{"name":"Neurology Unit, Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Borroni","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy"},{"name":"Molecular Markers Laboratory, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2025,12,8]]},"reference":[{"issue":"20","key":"zoi251264r2","doi-asserted-by":"publisher","first-page":"4260","DOI":"10.1016\/j.cell.2023.08.021","article-title":"Alzheimer\u2019s disease: From immunotherapy to immunoprevention.","volume":"186","author":"Jucker","year":"2023","journal-title":"Cell"},{"key":"zoi251264r3","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.ijpsycho.2015.02.008","article-title":"Brain neural synchronization and functional coupling in Alzheimer\u2019s disease as revealed by resting state EEG rhythms.","volume":"103","author":"Babiloni","year":"2016","journal-title":"Int J Psychophysiol"},{"issue":"7632","key":"zoi251264r4","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/nature20587","article-title":"Gamma frequency entrainment attenuates amyloid load and modifies microglia.","volume":"540","author":"Iaccarino","year":"2016","journal-title":"Nature"},{"issue":"8","key":"zoi251264r5","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1038\/s41596-018-0021-x","article-title":"Noninvasive 40-Hz light flicker to recruit microglia and reduce amyloid beta load.","volume":"13","author":"Singer","year":"2018","journal-title":"Nat Protoc"},{"issue":"2","key":"zoi251264r6","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.cell.2019.02.014","article-title":"Multi-sensory gamma stimulation ameliorates Alzheimer\u2019s-associated pathology and improves cognition.","volume":"177","author":"Martorell","year":"2019","journal-title":"Cell"},{"key":"zoi251264r7","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2024.1343588","article-title":"Safety, tolerability, and efficacy estimate of evoked gamma oscillation in mild to moderate Alzheimer\u2019s disease.","volume":"15","author":"Haj\u00f3s","year":"2024","journal-title":"Front Neurol"},{"issue":"s1","key":"zoi251264r8","doi-asserted-by":"publisher","first-page":"S545","DOI":"10.3233\/JAD-230535","article-title":"Brain stimulation in Alzheimer\u2019s disease trials.","volume":"101","author":"Benussi","year":"2024","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"zoi251264r9","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1523\/JNEUROSCI.4227-13.2014","article-title":"Precuneus is a functional core of the default-mode network.","volume":"34","author":"Utevsky","year":"2014","journal-title":"J Neurosci"},{"issue":"3","key":"zoi251264r10","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.brs.2021.03.007","article-title":"Exposure to gamma tACS in Alzheimer\u2019s disease: a randomized, double-blind, sham-controlled, crossover, pilot study.","volume":"14","author":"Benussi","year":"2021","journal-title":"Brain Stimul"},{"issue":"2","key":"zoi251264r11","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1002\/ana.26411","article-title":"Increasing brain gamma activity improves episodic memory and restores cholinergic dysfunction in Alzheimer\u2019s disease.","volume":"92","author":"Benussi","year":"2022","journal-title":"Ann Neurol"},{"issue":"4","key":"zoi251264r12","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: toward a biological definition of Alzheimer\u2019s disease.","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"issue":"1","key":"zoi251264r13","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.1016\/j.jalz.2012.01.005","article-title":"Progression of Alzheimer\u2019s disease as measured by Clinical Dementia Rating Sum of Boxes scores.","volume":"9","author":"Williams","year":"2013","journal-title":"Alzheimers Dement"},{"issue":"1","key":"zoi251264r14","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13195-015-0151-0","article-title":"New scoring methodology improves the sensitivity of the Alzheimer\u2019s Disease Assessment Scale\u2013cognitive subscale (ADAS-Cog) in clinical trials.","volume":"7","author":"Verma","year":"2015","journal-title":"Alzheimers Res Ther"},{"key":"zoi251264r15","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1097\/00002093-199700112-00005","article-title":"An inventory to assess activities of daily living for clinical trials in Alzheimer\u2019s disease: the Alzheimer\u2019s Disease Cooperative Study.","volume":"11","author":"Galasko","year":"1997","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"9","key":"zoi251264r16","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.1016\/j.neuropsychologia.2011.06.006","article-title":"Face-name associative memory performance is related to amyloid burden in normal elderly.","volume":"49","author":"Rentz","year":"2011","journal-title":"Neuropsychologia"},{"issue":"4","key":"zoi251264r18","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/1097-4679(198707)43:4<402::AID-JCLP2270430411>3.0.CO;2-E","article-title":"Relationships between parts A and B of the Trail Making Test.","volume":"43","author":"Corrigan","year":"1987","journal-title":"J Clin Psychol"},{"issue":"12","key":"zoi251264r19","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1212\/WNL.44.12.2308","article-title":"The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia.","volume":"44","author":"Cummings","year":"1994","journal-title":"Neurology"},{"issue":"6","key":"zoi251264r20","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1093\/geront\/29.6.798","article-title":"Application of a multidimensional caregiver burden inventory.","volume":"29","author":"Novak","year":"1989","journal-title":"Gerontologist"},{"issue":"3","key":"zoi251264r21","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/ana.24731","article-title":"Impaired long-term potentiation-like cortical plasticity in presymptomatic genetic frontotemporal dementia.","volume":"80","author":"Benussi","year":"2016","journal-title":"Ann Neurol"},{"issue":"2","key":"zoi251264r22","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.neuroimage.2011.09.015","article-title":"FSL.","volume":"62","author":"Jenkinson","year":"2012","journal-title":"Neuroimage"},{"issue":"4","key":"zoi251264r23","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1177\/1971400917697342","article-title":"Resting state fMRI: a review on methods in resting state connectivity analysis and resting state networks.","volume":"30","author":"Smitha","year":"2017","journal-title":"Neuroradiol J"},{"issue":"1","key":"zoi251264r24","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jneumeth.2003.10.009","article-title":"EEGLAB: an open source toolbox for analysis of single-trial EEG dynamics including independent component analysis.","volume":"134","author":"Delorme","year":"2004","journal-title":"J Neurosci Methods"},{"issue":"1","key":"zoi251264r25","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s13195-023-01297-4","article-title":"Home-based transcranial alternating current stimulation (tACS) in Alzheimer\u2019s disease: rationale and study design.","volume":"15","author":"Altomare","year":"2023","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"zoi251264r26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v067.i01","article-title":"Fitting linear mixed-effects models using lme4.","volume":"67","author":"Bates","year":"2015","journal-title":"J Stat Softw"},{"issue":"20","key":"zoi251264r27","doi-asserted-by":"crossref","first-page":"4829","DOI":"10.1093\/bioinformatics\/btac567","article-title":"SEMgraph: an R package for causal network inference of high-throughput data with structural equation models.","volume":"38","author":"Grassi","year":"2022","journal-title":"Bioinformatics"},{"issue":"1","key":"zoi251264r28","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s13195-024-01570-0","article-title":"Transcranial Alternating Current Stimulation for Patients With Mild Alzheimer\u2019s Disease (TRANSFORM-AD): a randomized controlled clinical trial.","volume":"16","author":"Tang","year":"2024","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"zoi251264r29","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s40035-024-00423-y","article-title":"Transcranial alternating current stimulation (tACS) at gamma frequency: an up-and-coming tool to modify the progression of Alzheimer\u2019s Disease.","volume":"13","author":"De Paolis","year":"2024","journal-title":"Transl Neurodegener"},{"issue":"12","key":"zoi251264r30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0278412","article-title":"Gamma frequency sensory stimulation in mild probable Alzheimer\u2019s dementia patients: results of feasibility and pilot studies.","volume":"17","author":"Chan","year":"2022","journal-title":"PLoS One"},{"key":"zoi251264r17","volume-title":"L\u2019Examen Clinique en Psychologie","author":"Rey","year":"1964"},{"key":"zoi251264r1","unstructured":"World Alzheimer Report 2022: life after diagnosis: navigating treatment, care and support. Alzheimer\u2019s Disease International. September 21, 2022. Accessed December 27, 2022. https:\/\/www.alzint.org\/resource\/world-alzheimer-report-2022\/?"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2842460\/cantoni_2025_oi_251264_1764627106.00374.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T16:00:30Z","timestamp":1765209630000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2842460"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2025,12,8]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.46556","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,8]]}}}